Introduction
Antibiotic resistance is a major problem worldwide 1 and the lack of new efficacious 48 antibiotics has severely limited the therapeutic options for treating bacterial infections. 2 
49
Carbapenems are an important class of antibiotics, increasingly used as a last option in 50 treating serious bacterial infections. 3 Use of these antibiotics has been threatened by the 51 emergence and dissemination of carbapenemase enzymes which have a broad-spectrum 52 hydrolytic profile. These carbapenemase enzymes include the Klebsiella pneumoniae 53 carbapenemase (KPC), New Delhi metallo-β-lactamase (NDM), oxacillinase group β-54 lactamase (OXA), Verona integron-encoded metallo-β-lactamase (VIM) and imipenemase-55 type metallo-β-lactamase (IMP) 4 . Moreover, carbapenemase-producing Enterobacteriaceae 56 (CPE) are often resistant to other classes of antibiotics, limiting the available therapeutic 57 options and leading to therapy failure. 5 
58
Detection of CPE has traditionally been achieved using phenotypic tests that determine 59 susceptibility to selected β-lactams; however, these tests can be unreliable. Some isolates of 60 CPE are inhibited by carbapenem MIC values below recommended breakpoint 61 concentrations and the clinical implications for treatment with carbapenems are debated. 62
The CLSI carbapenem breakpoint concentrations were revised in 2010, where isolates 63 previously classified as carbapenem-susceptible are now classified as carbapenem non-64 susceptible. However, phenotypic antimicrobial susceptibility testing does not always 65 demonstrate concordance with carbapenemase activity.
6-8 EUCAST (http://www.eucast.org/) 66 recommends very low cut-off points for identifying potential CPE. The heterogeneity in 67
carbapenem MIC values observed in CPE may be associated with the diverse combinations 68 of resistance mechanisms that can be present in each isolate. 9 The absence of outer 69 membrane porin proteins such as the OmpK35 (OmpF homologue) and OmpK36 (OmpC 70 homologue) have been shown to affect the susceptibility of carbapenemase-producing K. 71 pneumoniae to carbapenems.
10, 11
The resistance nodulation division (RND) efflux systems found amongst Gram-negative 73
Enterobacteriaceae confer resistance to many antimicrobial compounds. 12 The AcrAB-TolC 74 efflux system is the best-studied RND efflux system and it extrudes a wide variety of 75 substrates including different classes of antibiotics. It has been well established that 76 production of AcrAB-TolC is associated with resistance to some β-lactam antibiotics, 77 including penicillins and cephalosporins. 12 Pages et al. have suggested that there is a 78 synergistic effect between AcrAB-TolC and β-lactamase enzymes in conferring resistance to 79 β-lactam antibiotics in K. pneumoniae. 13 They showed that various clinical isolates producing 80 the chromosomal SHV-1 β-lactamase were more susceptible to piperacillin in the presence 81 of tazobactam (a β-lactamase inhibitor) and PAβN (an efflux inhibitor). In the presence of 82 tazobactam, the MIC values of piperacillin for the isolates decreased 4-to 8-fold. However, 83
in the presence of both tazobactam and PAβN, the susceptibility of the isolates increased by 84 a further 4-fold. The authors suggested that tazobactam was a substrate of the AcrAB-TolC 85 efflux system, hence, inhibition of the efflux system by PAβN increased the periplasmic 86 concentration of tazobactam, allowing a stronger protective effect of the β-lactamase 87 inhibitor on the SHV-1 enzyme. 13 However, it has also been shown that inactivation of 88 AcrAB-TolC in E. coli resulted in a 16-fold increase in susceptibility of the bacterium to 89 piperacillin.
14 Therefore, it is also possible that the larger increase in susceptibility of the K. 90 pneumoniae isolates to piperacillin in the presence of tazobactam and PAβN was a result of 91 the combined loss of the functions of the SHV-1 β-lactamase and the efflux system. AcrAB-92
TolC has also been shown to play an important role in resistance to fluoroquinolones and 93 triclosan by acting synergistically with other, specific resistance mechanisms for these 94 agents.
15, 16 However, not much is known about the contribution of the AcrAB-TolC efflux 95 system to carbapenem resistance and any possible synergy with carbapenemases. 96
In this study, we investigated whether a functional AcrAB-TolC efflux system is required for 97 full elaboration of resistance towards a variety of clinically important carbapenems in 98 carbapenemase-producing bacteria.
Materials and Methods 100

Bacterial strains, plasmid and growth conditions 101
All plasmids and bacterial strains used in this study are listed in Table 1 14028s were constructed as previously described using 100 mg/L rifampicin. 17 The Ecl8
Rif 107 tolC::aph was generated by inactivating the tolC gene in the rifampicin-resistant Ecl8 Rif as 108 previously described. 18 The acrB::aph (EG16566) and tolC::aph (EG16564) alleles were 109 transduced with P22 into 14028s
Rif to generate isogenic efflux mutants. The plasmids were 110 transferred into the various strains using filter-mating. 19 All strains constructed were verified 111 by PCR and DNA sequencing as containing desired genes or mutations (Table 2) . 112
Eighty-six non-replicate clinical isolates of CPE collected from referrals to the AMRHAI 113
Reference Unit of PHE were studied. These included Klebsiella oxytoca (n = 4), K. 114 pneumoniae (n = 25), Enterobacter asburiae (n = 1), Enterobacter aerogenes (n = 3), 115
Enterobacter cloacae (n = 22), Enterobacter gergoviae (n = 2) and E. coli (n = 29). Each of 116 these strains carried one of the major carbapenemase genes found in the UK i.e. bla NDM (n = 117 20) and bla KPC (n = 20), bla OXA-48 -like (n = 18), bla VIM (n = 16), or bla IMP (n = 12). 118
Determination of antibiotic susceptibility 119
The minimum inhibitory concentration (MIC) of each antibiotic for the bacterial strains and 120 clinical isolates was determined using the agar dilution method and interpretation as 121 described by the BSAC. 20 Where efflux inhibitors were tested, the concentrations used were: 122 phenylalanine-arginine-β-naphthylamide (PAβN; 25 mg/L); 3 µM CCCP; 1-(1-123 naphthylmethyl)-piperazine (NMP; 100 mg/L). All chemicals were obtained from Sigma-124 Aldrich, USA. The MICs were determined on at least two separate occasions.
Outer membrane protein (porin) extraction and sodium dodecyl sulphate polyacrylamide gel 126 electrophoresis (SDS-PAGE) 127
Bacterial outer membrane proteins were purified as previously described. 21 Briefly, an 128 overnight culture of bacteria was incubated at 37°C until it reached an OD 600 of 0.6. Cell 129 pellets were obtained after centrifugation and washing in 50 mM sodium phosphate buffer 130 pH 7.0, freezing overnight at -80°C. The thawed cell suspension sonicated for 30 seconds 131 four times with 30-second intervals to avoid overheating and the cell lysates were 132 centrifuged at 6,000 x g for 1 min at 4°C to discard larger cell debris. The supernatants were 133 then centrifuged again at 12,000 x g for 30 min at 4°C and pellets re-suspended vigorously 134 in 200 μL 2% sarcosyl and incubated at room temperature for 30 min. The samples were 135 centrifuged again at 12,000 x g for 30 min at 10°C. All the supernatant was carefully 136 removed to ensure most of the detergent containing solution had been removed. The protein 137 pellet was resuspended in 100 μL of 50 mM sodium phosphate buffer pH 7.0 and 138 centrifuged at 12,000 x g for 10 min at 4°C to remove residual detergent from the outer 139 membrane protein preparations. The supernatant was discarded and the extracted outer 140 membrane proteins were finally resuspended in 50 μL of 50 mM sodium phosphate buffer 141 pH 7.0. The amount of total protein in each sample was quantified using the Bradford assay. 142
The extracted outer membrane proteins were separated by SDS-PAGE using 16 x 20 x 0.1 143 cm discontinuous gels (4% stacking gel and 10 % resolving gel). Sample loading buffer 144 (Sigma-Aldrich) was added to the protein samples which were heated at 95°C for 10 min. A 145 total of 2 µg of total protein was loaded per lane for separation. Once the protein samples 146 had been loaded into the wells, electrophoresis was started using 100 volts (constant) until 147 the samples migrated into the resolving gel where the voltage was increased to 200 volts. 148 Gels were stained with PhastGel ® Blue R (Sigma-Aldrich) for 1 hour with gentle shaking. 149
Then, gels were de-stained using de-staining buffer [10% (v/v) methanol and 5% (v/v) acetic 150 acid in water] overnight with gentle shaking. The de-stained gels were visualised and images 151 taken a using G:Box Gel Documentation System (Syngene, Cambridge, UK).
Despite repeated attempts to improve the resolution of the Salmonella porin proteins on SDS 153 PAGE, this proved challenging. Therefore, to confirm the identity of the protein bands mass 154 spectrometry was carried out on the bands from gels containing 6 µg of total protein that had 155 migrated to the molecular sizes typical of OmpC and OmpF. Gel slices were excised from 156 the gel and processed at the Advanced Mass Spectrometry Facility of the University of 157
Birmingham. Briefly, bands were subjected to digestion with trypsin and 10µL of extracted 158 protein in 1% Formic Acid was then used to separate and analyse digested peptides using 159
an Orbitrap Velos (Thermo Scientific). TurboSEQUEST software (Thermo Scientific) was 160 used to analyse data and assign protein identities to samples. 161
Results
163
Inactivation of a gene encoding a component of the AcrAB-TolC efflux pump increases β-164 lactam resistance 165
There was no significant difference in the MICs of β-lactam antibiotics for the plasmid-free K. 166 pneumoniae Ecl8 and its isogenic AcrAB and TolC mutants (Table 3) . However, when 167 pKpQIL-UK carrying bla KPC-2 was present, the AcrAB mutant strain (Ecl8 Rif pKPQIL-UK 168 acrAB::aph) was 8-and 4-fold less susceptible than the parental strain (Ecl8 Rif ) to ertapenem 169 and meropenem, respectively. E. coli BW25113 acrB::aph carrying pKpQIL-UK also showed 170 a 4-fold decrease in susceptibility to ertapenem. However, the E. coli BW25113 TolC mutant 171 (without plasmid) showed a 4-fold increase in susceptibility to doripenem and biapenem 172
(when compared to BW25113). This strain carrying pKpQIL-UK (BW25113 pKpQIL-UK 173 tolC::aph) was also more susceptible to meropenem, doripenem, biapenem and ceftazidime 174 than BW25113 containing pKpQIL-UK. In contrast to E. coli, S. Typhimurium 14028s 175 tolC::aph carrying pKpQIL-UK was less susceptible to ertapenem, meropenem, doripenem 176 and ceftazidime. With the exception of the E. coli TolC mutant, these data suggest that lack 177 of AcrAB or TolC can increase the MICs of some carbapenems for some Enterobacteriaceae. 178
To determine whether increased expression of acrAB or tolC in Salmonella affected 179 carbapenem MICs, pKpQIL-UK was introduced into S. Typhimurium 14028S ramR::aph. No 180 differences in MIC values to those of 14028s were detected (data not shown). 181
Decreased susceptibility to β-lactam antibiotics in efflux pump mutants carrying β-182 lactamases is independent of the vector and β-lactamase gene 183
To investigate whether the observed decreases in carbapenem susceptibility in the pKpQIL-184 UK carrying efflux mutants were a specific feature of this plasmid or gene or a general 185 phenomenon, two other clinically important plasmids (pNDM-HK and pCT) plus a laboratory 186 vector, pUC18, were introduced into a series of isogenic mutants of S. Typhimurium 14028s 187 lacking defined efflux components (Table 3) . Each plasmid also carried a β-lactamase gene,NDM-1, CTX-M-14 and TEM-1, respectively. In the presence of the NDM-1 carrying pNDM-189 HK, the Salmonella TolC mutant was again 4-fold less susceptible to ertapenem and 190 meropenem. The presence of pCT in the TolC mutant also decreased its susceptibility to 191 ceftazidime by 8-fold, but had no affect on the activity of carbapenems. To determine 192 whether the data obtained with 14028s and mutants was strain specific, the MICs of 193 antibiotics for S. Typhimurium SL1344 and its isogenic efflux mutants (∆acrA, ∆acrB and 194 ∆tolC) carrying a bla TEM-1 encoding plasmid (pUC18) were also determined. Except for 195 ertapenem (4-fold less susceptible), no difference was observed in the MIC values for the 196
various β-lactam antibiotics tested for the TolC mutant, a 4-fold decrease in susceptibility to 197 biapenem was seen in the AcrAB mutant (Table 3 ). These data suggest that the reduced 198 susceptibility to β-lactam antibiotics observed in S. Typhimurium lacking TolC or AcrB is not 199 specific to the host strain, plasmid or β-lactamase gene it carries. Rif carrying the pKpQIL-UK 212 plasmid. However, in the presence of PAβN, there was a 16-and 4-fold increase in 213 susceptibility to ertapenem, respectively, for the isogenic K. pneumoniae Ecl8
Rif AcrAB and 214
TolC mutants carrying pKpQIL-UK.
PAβN increases ertapenem resistance in clinical isolates of Enterobacteriaceae 216
As our data suggested that PAβN conferred increased resistance to some β-lactam 217 antibiotics, it was hypothesised that the PAβN effect would be observed with clinical isolates 218 of carbapenemase producing Enterobacteriaceae. In the presence of 25 mg/L PAβN, 42% 219 (n = 36) of the panel of curated CPE isolates became 4-fold or more resistant to ertapenem 220 (Table 5) MIC value, respectively. Twenty isolates (ca. 23%) showed more than a 2-fold increase in 230 ertapenem susceptibility. The 36 isolates for which 25 mg/L PAβN conferred a 4-fold or more 231 increase in the ertapenem MIC were affected differently when 100 mg/L PAβN was used 232 (Table 6 ). At the higher PAβN concentration, only seven of the isolates were 4-fold less 233 susceptible to ertapenem compared to when no PAβN was added. Of the remaining isolates, 234 23 were 2-fold less susceptible and 6 isolates had no change in ertapenem MIC value. 235
PAβN reduces outer membrane protein expression, which is associated with increased 236 resistance to carbapenems 237
It was hypothesised that the PAβN effect on the MICs of ertapenem and the other 238 carbapenems was due to altered expression of outer membrane proteins, possibly porin 239
proteins. In the presence of the plasmid pKpQIL-UK, the increase in ertapenem MIC value 240 was more apparent for a mutant lacking OmpF (8-fold increase) and an OmpC-OmpF doublemutant (16-fold increase) than an OmpC mutant (Table 4) . When PAβN was present, this 242 increase in carbapenem resistance was greater for the S. Typhimurium OmpC mutant (16-243 fold), than the OmpF and OmpCF mutants (4-fold) (Table 4 ). In the presence of NMP, a 244 decrease in susceptibility was also observed in S. Typhimurium SL1344 and its isogenic 245
OmpC mutant. These data suggest that OmpF plays a more important role than OmpC in 246 the observed changes in susceptibility to ertapenem. 247
From the MIC data (Table 4) , the loss of outer membrane proteins (OmpC and OmpF) was 248 associated with the reduction in susceptibility of the S. Typhimurium strains towards 249 ertapenem. Hence, it was hypothesised that the repression of outer membrane proteins 250 (OmpC and OmpF) resulted in the reduced β-lactam antibiotic susceptibility in the S. 251
Typhimurium TolC mutants. Therefore, the expression of outer membrane proteins of the 252 Salmonella strains in the absence of efflux pump components and when treated with PAβN 253 were investigated. However, no obvious differences were observed for the efflux pump 254 mutants compared to the wildtype S. Typhimurium SL1344 SDS-PAGE (Figure 1) . 255
As sixty-two Enterobacteriaceae clinical isolates had reduced susceptibility to ertapenem in 256 the presence of PAβN (Table 5) , it was hypothesised that PAβN altered the outer membrane 257 and/or porin expression in these isolates, resulting in reduced susceptibility to ertapenem. 258
Hence, SDS-PAGE of four isolates each of E. coli, Enterobacter spp and five isolates of 259
Klebsiella which were less susceptible to ertapenem in the presence of 25 mg/L PAβN was 260 carried out. The outer membrane protein profile of one isolate of each species for which the 261 ertapenem MIC was not affected by the presence of PAβN was also determined. Isolates 262 which showed an increase in ertapenem resistance in the presence of PAβN also had 263 reduced expression of OmpF (or equivalent) when PAβN was added (Figure 2 ). E. coli 656, 264 K. pneumoniae 664 and E. asburiae 278 which showed no differences in ertapenem MIC 265 value when PAβN was added showed no OmpF (or its orthologue) changes. In conclusion, 266 in the isolates for which PAβN increased ertapenem MIC values, the compound also altered 267 porin expression.
Discussion 269
Previous studies have shown that in E. coli the AcrAB-TolC efflux system works 270 synergistically with other mechanisms to confer a higher level of resistance to antibacterial 271 compounds, such as triclosan and ciprofloxacin.
15, 16 As a consequence, inhibition of efflux or 272 deletion of a component of AcrAB-TolC often increases susceptibility to antibiotics. However, 273 data obtained from our study suggest that a functional AcrAB-TolC is not required for 274 carbapenem resistance and that AcrAB-TolC does not act synergistically with 275
carbapenemases. This finding corroborates a previous study which found no increase in 276 expression of acrB mRNA transcripts among carbapenem-resistant isolates of Klebsiella spp. 277
and Enterobacter spp. 22 Moreover, to date, there is no study that clearly associates 278 carbapenems (in particular, ertapenem) as a substrate of the AcrAB-TolC efflux system or its 279 orthologue in P. aeruginosa. 280
Counter-intuitively, the loss of TolC in S. Typhimurium carrying carbapenemase encoding 281 plasmids was associated with an increase in the MICs of a variety of carbapenem antibiotics 282 (ertapenem, meropenem and doripenem) and a cephalosporin (ceftazidime). Although as 283 expected, the bla TEM-1 -encoding pUC18 plasmid did not confer a clinically significant level of 284 resistance to ertapenem in the Salmonella TolC mutant (SL1344 ∆TolC pUC18), the fold 285 increase in the ertapenem MIC (when compared with the SL1344 pUC18) was similar to 286 those shown for strains containing the carbapenemase-encoding plasmids pKpQIL-UK and 287 pNDM-HK. Taken together, these data suggest that the increase in β-lactam (especially 288 carbapenem) resistance in the Salmonella TolC mutant was not an artefact of one vector, 289 nor was it an effect of the specific carbapenemase or β-lactamase. This finding is similar to 290 those reported for clinical isolates harbouring different carbapenemases and which showed 291 heteroresistance towards various carbapenem antibiotics. [23] [24] [25] The addition of the efflux 292 inhibitor, PAβN, increased the ertapenem MICs for the wild-type S. Typhimurium 14028s pKpQIL-UK (KPC-2) were increased, with the greatest change seen after addition of PAβN 315 seen for the OmpC mutant. Taken together, these data suggest that altered porin production 316 was associated with the observed reduction in ertapenem susceptibility in the efflux mutant 317 strains carrying the plasmids. This was supported by the SDS-PAGE gels, which showed a 318 decrease in Salmonella porin expression with an increasing concentration of PAβN. Similar 319 changes in outer membrane protein profile were observed with the clinical isolates of 320
Enterobacteriaceae harbouring a variety of carbapenemases. These findings support aprevious study which showed OmpC and OmpF or their orthologues play a role in 322 carbapenem resistance among Enterobacter spp. and Klebsiella spp. 22 
323
To investigate whether the decrease in carbapenem susceptibility was specific to PAβN, 324
MICs of ertapenem were determined with two other efflux inhibitors (NMP and CCCP) for S. 325
Typhimurium 14028s
Rif carrying the pKpQIL-UK plasmid. This carbapenem was chosen as it 326
showed the largest change in susceptibility. Independent of the presence of a functional 327 AcrAB-TolC efflux system, PAβN and NMP reduced the susceptibility of the Salmonella and 328 E. coli strains harbouring the pKpQIL-UK plasmid. The regulation of porin expression is 329 known to be complex and differs between species. 35, 36 This may explain the differences 330 observed between the K. pneumoniae, E. coli and S. Typhimurium efflux mutants' 331 susceptibility to the antibiotics tested. However, as distinguishing between OmpF and OmpC 332 on SDS-PAGE was challenging with the Salmonella mutants it is possible that subtle 333 differences in porin production were not detected. 334
It is well established that AcrAB-TolC contributes to inherent and acquired antibiotic 335 resistance and that TolC forms the outer membrane channel of most MDR efflux pumps 336 found in Enterobacteriaceae. Hence, this system and/or TolC alone have been suggested as 337 a potential target for efflux inhibitors. 37 Our work has shown that addition of PAβN or loss of 338 a component of a MDR efflux pump such as TolC increased resistance of bacteria against 339 some antibiotics, which use outer membrane porins as entry routes into the bacterial cell. 340
Hence, TolC may not be an ideal drug target as the loss of TolC or inhibition of efflux 341 function may confer increased resistance to some β-lactams. Therefore, we recommend 342 careful evaluation of new efflux inhibitors to ensure that there is no increased resistance to 343 clinically important antibiotics in antibiotic resistant bacteria. 344
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